Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Jezzard

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Discovery Medicine|August 14, 2010
Genetically engineered E. coli as a protein delivery vehicle for killing cancer cellsRebecca J Critchley, Sarah Jezzard, Georges Vassaux
Human Gene Therapy|December 9, 2004
Direct comparison of the insulating properties of two genetic elements in an adenoviral vector containing two different expression cassettesPilar Martin-Duque, Sarah Jezzard, Lambrini Kaftansis, et al.
The Journal of Pathology|December 20, 2005
Bacterial gene therapy strategiesGeorges Vassaux, Josianne Nitcheu, Sarah Jezzard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2002
Secretin-mediated gene delivery, a specific targeting mechanism with potential for treatment of biliary and pancreatic disease in cystic fibrosisTristan McKay, Paul Reynolds, Sarah Jezzard, et al.
Cancer Research|August 17, 2006
Assessment of endostatin gene therapy for familial adenomatous polyposis-related desmoid tumorsSandra C M Martinico, Sarah Jezzard, N Julian H Sturt, et al.
Blood|October 24, 2002
In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factorSimon N Waddington, Suzanne M K Buckley, Megha Nivsarkar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Discovery Medicine|August 14, 2010
Genetically engineered E. coli as a protein delivery vehicle for killing cancer cellsRebecca J Critchley, Sarah Jezzard, Georges Vassaux
Human Gene Therapy|December 9, 2004
Direct comparison of the insulating properties of two genetic elements in an adenoviral vector containing two different expression cassettesPilar Martin-Duque, Sarah Jezzard, Lambrini Kaftansis, et al.
The Journal of Pathology|December 20, 2005
Bacterial gene therapy strategiesGeorges Vassaux, Josianne Nitcheu, Sarah Jezzard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2002
Secretin-mediated gene delivery, a specific targeting mechanism with potential for treatment of biliary and pancreatic disease in cystic fibrosisTristan McKay, Paul Reynolds, Sarah Jezzard, et al.
Cancer Research|August 17, 2006
Assessment of endostatin gene therapy for familial adenomatous polyposis-related desmoid tumorsSandra C M Martinico, Sarah Jezzard, N Julian H Sturt, et al.
Blood|October 24, 2002
In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factorSimon N Waddington, Suzanne M K Buckley, Megha Nivsarkar, et al.
Pageof 1